Mark Cziraky
About Mark Cziraky
Mark Cziraky serves as the President of Carelon Research, bringing extensive experience in health economics and clinical trials. He previously held leadership roles at HealthCore, Anthem, and Saint Joseph's University, contributing to research and development in the life sciences sector.
Current Role at Carelon Research
Mark Cziraky serves as the President at Carelon Research, a position he has held since 2023. In this role, he oversees research initiatives and strategic direction within the organization. His leadership focuses on advancing research methodologies and enhancing the impact of clinical studies. Cziraky's experience in the field positions him to drive innovation and foster collaboration among research teams.
Previous Experience at HealthCore, Inc.
Cziraky co-founded HealthCore, Inc. and served as Executive Vice President from 1996 to 2003. During his tenure, he contributed to the establishment of the company as a leader in health research. His role involved overseeing research operations and ensuring the delivery of high-quality outcomes in health economics and outcomes research.
Professional Background at Anthem, Inc.
Mark Cziraky worked at Anthem, Inc. in various capacities, including Vice President of Scientific Affairs and Chief Growth Officer at HealthCore for 10 months in 2020. Prior to that, he was Vice President of Industry Sponsored Research from 2003 to 2020. In these roles, he focused on strategic research initiatives and partnerships within the healthcare sector.
Academic Qualifications
Cziraky studied at Saint Joseph's University, where he earned a BS and PharmD in Pharmacy from 1987 to 1993. He furthered his education in Ambulatory Care Pharmacy Practice, completing a residency from 1993 to 1994. Additionally, he served as an Assistant Professor of Clinical Pharmacy at the same university from 1994 to 1997, contributing to the education of future pharmacists.
Expertise in Clinical Trials and Research
Mark Cziraky has extensive experience in designing and conducting pragmatic clinical trials. He has led large-scale multispecialty research operational teams and possesses significant expertise in safety and epidemiology research. His background in health economics and outcomes research supports his ability to develop strategic research initiatives across life sciences companies.